Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.
J Extracell Vesicles. 2023 Jul;12(7):e12332. doi: 10.1002/jev2.12332.
J Extracell Vesicles. 2023.
PMID: 37353884
Free PMC article.
Clinical Trial.
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.
Sejic N, George LC, Tierney RJ, Chang C, Kondrashova O, MacKinnon RN, Lan P, Bell AI, Lessene G, Long HM, Strasser A, Shannon-Lowe C, Kelly GL.
Sejic N, et al.
Blood Adv. 2020 Oct 13;4(19):4775-4787. doi: 10.1182/bloodadvances.2020002446.
Blood Adv. 2020.
PMID: 33017468
Free PMC article.
Item in Clipboard
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith LCA, Suraweera CD, Croom-Carter D, Dewson G, Tierney RJ, Bell AI, Shannon-Lowe C, Herold MJ, Rickinson AB, Colman PM, Huang DCS, Strasser A, Kvansakul M, Rowe M, Kelly GL.
Fitzsimmons L, et al. Among authors: sejic n.
Cell Death Differ. 2020 May;27(5):1554-1568. doi: 10.1038/s41418-019-0435-1. Epub 2019 Oct 23.
Cell Death Differ. 2020.
PMID: 31645677
Free PMC article.
Item in Clipboard
Cite
Cite